Abstract
Patients with invasive cancer of the breast (T1-4, N0-2, M0) were assigned to pretreatment based on oestrogen receptor (ER) status; patients with ER-negative tumours received chemotherapy [mitozantrone, methotrexate and mitomycin C (MMM)] for 3 months, patients with ER-positive tumours underwent endocrine therapy [luteinising hormone releasing hormone (LHRH) agonist goserelin (leuprolide-premenopausal) or 4-hydroxyandrostenedione (formestane-post-menopausal)] for 3 months. Of the first 100 patients assessed at 3 months, 47 with ER-positive tumours had a 40.4% response (premenopausal 53.8%; post-menopausal 35%) and 53 with ER-negative tumours had a 60% response (premenopausal 57%; post-menopausal 63%). Patients with early breast cancer (T1/T2) had a complete clinical resolution in 41% (16/39) of cases after MMM and in 20% (7/35) of cases following endocrine therapy compared with 14% (2/14) advanced tumours (T3/T4) following MMM and (0/12) following endocrine therapy. However, in those patients achieving a complete clinical response, subsequent appropriate surgery showed that 16 of 19 patients (84%) had evidence of residual viable tumour on histological examination.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gazet, JC., Coombes, R., Ford, H. et al. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Br J Cancer 73, 758–762 (1996). https://doi.org/10.1038/bjc.1996.132
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.132
- Springer Nature Limited
This article is cited by
-
Evaluation of Histomorphological Changes in Breast Cancer Post-Neoadjuvant Chemotherapy
Indian Journal of Surgical Oncology (2024)
-
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?
Breast Cancer Research and Treatment (2024)
-
Endocrine Therapy in the Preoperative Setting and Strategies to Overcome Resistance
Current Breast Cancer Reports (2011)
-
Locally advanced breast cancer in octogenarian women
Breast Cancer Research and Treatment (2005)